William E Barlow

Summary

Affiliation: Fred Hutchinson Cancer Research Center
Country: USA

Publications

  1. pmc Variability of interpretive accuracy among diagnostic mammography facilities
    Sara L Jackson
    Department of Internal Medicine, University of Washington School of Medicine, Box 359854, Seattle, WA 98104, USA
    J Natl Cancer Inst 101:814-27. 2009
  2. pmc Overview of methods to estimate the medical costs of cancer
    William E Barlow
    Department of Biostatistics, University of Washington, Seattle, Washington 98101, USA
    Med Care 47:S33-6. 2009
  3. pmc Accuracy of screening mammography interpretation by characteristics of radiologists
    William E Barlow
    Cancer Research and Biostatistics, 1730 Minor Ave, Ste 1900, Seattle WA 98101, USA
    J Natl Cancer Inst 96:1840-50. 2004
  4. ncbi request reprint Prospective breast cancer risk prediction model for women undergoing screening mammography
    William E Barlow
    Cancer Research and Biostatistics, 1730 Minor Avenue, Suite 1900, Seattle, WA 98101, USA
    J Natl Cancer Inst 98:1204-14. 2006
  5. pmc Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer
    Lisa K Dunnwald
    Department of Bioengineering, Division of Nuclear Medicine, University of Washington, Seattle, WA, USA
    J Clin Oncol 26:4449-57. 2008
  6. pmc Mammographers' perception of women's breast cancer risk
    Joseph R Egger
    Division of General Internal Medicine, University of Washington School of Medicine, Harborview Medical Center, Seattle, WA 98104 2499, USA
    Med Decis Making 25:283-9. 2005
  7. ncbi request reprint Efficacy of breast cancer screening in the community according to risk level
    Joann G Elmore
    School of Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA
    J Natl Cancer Inst 97:1035-43. 2005
  8. pmc Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammography
    Joann G Elmore
    Dept of Internal Medicine, Univ of Washington School of Medicine, Harborview Medical Ctr, 325 Ninth Ave, Box 359780, Seattle, WA 98104 2499, USA
    Radiology 236:37-46. 2005
  9. pmc Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer: SWOG 0012
    Georgiana K Ellis
    Seattle Cancer Care Alliance, 825 Eastlake Ave East, Seattle, WA 98109 1023, USA
    J Clin Oncol 29:1014-21. 2011
  10. pmc Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer
    Diana S M Buist
    Group Health Research Institute, Group Health Cooperative, Seattle, WA 98101, USA
    Breast Cancer Res Treat 124:863-73. 2010

Detail Information

Publications51

  1. pmc Variability of interpretive accuracy among diagnostic mammography facilities
    Sara L Jackson
    Department of Internal Medicine, University of Washington School of Medicine, Box 359854, Seattle, WA 98104, USA
    J Natl Cancer Inst 101:814-27. 2009
    ..Interpretive performance of screening mammography varies substantially by facility, but performance of diagnostic interpretation has not been studied...
  2. pmc Overview of methods to estimate the medical costs of cancer
    William E Barlow
    Department of Biostatistics, University of Washington, Seattle, Washington 98101, USA
    Med Care 47:S33-6. 2009
    ..Methods to estimate the direct medical costs of cancer care have evolved into several commonly used methods...
  3. pmc Accuracy of screening mammography interpretation by characteristics of radiologists
    William E Barlow
    Cancer Research and Biostatistics, 1730 Minor Ave, Ste 1900, Seattle WA 98101, USA
    J Natl Cancer Inst 96:1840-50. 2004
    ..Radiologists differ in their ability to interpret screening mammograms accurately. We investigated the relationship of radiologist characteristics to actual performance from 1996 to 2001...
  4. ncbi request reprint Prospective breast cancer risk prediction model for women undergoing screening mammography
    William E Barlow
    Cancer Research and Biostatistics, 1730 Minor Avenue, Suite 1900, Seattle, WA 98101, USA
    J Natl Cancer Inst 98:1204-14. 2006
    ..We used prospective risk information to predict a diagnosis of breast cancer in a cohort of 1 million women undergoing screening mammography...
  5. pmc Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer
    Lisa K Dunnwald
    Department of Bioengineering, Division of Nuclear Medicine, University of Washington, Seattle, WA, USA
    J Clin Oncol 26:4449-57. 2008
    ..Serial positron emission tomography (PET) has been shown to predict pathologic response in this setting. We evaluated serial quantitative PET tumor blood flow (BF) and metabolism as in vivo measurements to predict patient outcome...
  6. pmc Mammographers' perception of women's breast cancer risk
    Joseph R Egger
    Division of General Internal Medicine, University of Washington School of Medicine, Harborview Medical Center, Seattle, WA 98104 2499, USA
    Med Decis Making 25:283-9. 2005
    ..To understand mammographers' perception of individual women's breast cancer risk...
  7. ncbi request reprint Efficacy of breast cancer screening in the community according to risk level
    Joann G Elmore
    School of Medicine, Harborview Medical Center, University of Washington, Seattle, WA, USA
    J Natl Cancer Inst 97:1035-43. 2005
    ..The efficacy of breast cancer screening in the community may differ from that suggested by the results of randomized trials, and no data have been available on efficacy among women who have different levels of breast cancer risk...
  8. pmc Does litigation influence medical practice? The influence of community radiologists' medical malpractice perceptions and experience on screening mammography
    Joann G Elmore
    Dept of Internal Medicine, Univ of Washington School of Medicine, Harborview Medical Ctr, 325 Ninth Ave, Box 359780, Seattle, WA 98104 2499, USA
    Radiology 236:37-46. 2005
    ..To assess the relationship between radiologists' perception of and experience with medical malpractice and their patient-recall rates in actual community-based clinical settings...
  9. pmc Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor as neoadjuvant therapy for inflammatory and locally advanced breast cancer: SWOG 0012
    Georgiana K Ellis
    Seattle Cancer Care Alliance, 825 Eastlake Ave East, Seattle, WA 98109 1023, USA
    J Clin Oncol 29:1014-21. 2011
    ..All patients had subsequent weekly paclitaxel for 12 weeks before surgery...
  10. pmc Diagnosis of second breast cancer events after initial diagnosis of early stage breast cancer
    Diana S M Buist
    Group Health Research Institute, Group Health Cooperative, Seattle, WA 98101, USA
    Breast Cancer Res Treat 124:863-73. 2010
    ..This study does not provide any evidence in support of changing surveillance intervals for different subgroups...
  11. pmc The association between obesity and screening mammography accuracy
    Joann G Elmore
    Division of General Internal Medicine, University of Washington School of Medicine, Harborview Medical Center, 325 Ninth Avenue, Box 359780, Seattle, WA 98104 2499, USA
    Arch Intern Med 164:1140-7. 2004
    ..Obesity is increasing among American women, especially as they age. The influence of obesity on the accuracy of screening mammography has not been studied extensively...
  12. pmc Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer
    Amanda I Phipps
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
    Ann Epidemiol 22:340-8. 2012
    ..However, relationships between these factors and risk of molecularly-defined subtypes of breast cancer have not been established...
  13. pmc Treatment expectations and preferences as predictors of outcome of acupuncture for chronic back pain
    Karen J Sherman
    Group Health Research Institute, Group Health Cooperative, Seattle, WA 98101, USA
    Spine (Phila Pa 1976) 35:1471-7. 2010
    ..Preplanned secondary analysis of data from participants receiving acupuncture in a randomized clinical trial...
  14. pmc Evaluating components of dental care utilization among adults with diabetes and matched controls via hurdle models
    Monica Chaudhari
    Washington Dental Service, 9706 Fourth Avenue NE, Seattle, WA 98115, USA
    BMC Oral Health 12:20. 2012
    ..This project had two purposes: to develop a methodology to estimate dental care utilization using claims data and to use this methodology to compare utilization of dental care between adults with and without diabetes...
  15. pmc Family history of breast cancer in first-degree relatives and triple-negative breast cancer risk
    Amanda I Phipps
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, M4 B402, PO Box 19024, Seattle, WA 98109 1024, USA
    Breast Cancer Res Treat 126:671-8. 2011
    ..Having a first-degree family history of breast cancer was associated with an increased risk of triple-negative breast cancer with a magnitude of association similar to that for the predominant ER+ subtype and ER-/PR-/HER2+ breast cancer...
  16. pmc Characteristics of patients with chronic back pain who benefit from acupuncture
    Karen J Sherman
    Group Health Research Institute, Seattle, USA
    BMC Musculoskelet Disord 10:114. 2009
    ..As part of a large trial evaluating acupuncture for chronic low back pain, we sought to identify subgroups of participants that were particularly responsive to acupuncture...
  17. ncbi request reprint Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception
    Delia Scholes
    Center for Health Studies, Group Health Cooperative, Seattle, Wash 98101, USA
    Arch Pediatr Adolesc Med 159:139-44. 2005
    ..Adolescents, who are still gaining bone, may be particularly affected, but there has been little study of the association in adolescent users and none following discontinuation...
  18. ncbi request reprint Promoting quality and evidence-based care in early-stage breast cancer follow-up
    N Lynn Henry
    Affiliations of authors Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI NLH, DFH Fred Hutchinson Cancer Research Center, University of Washington School of Medicine, Seattle, WA SDR, JRG Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX GNH Department of Biostatistics, University of Washington, Seattle, WA WEB
    J Natl Cancer Inst 106:dju034. 2014
    ..At this time, outside of well-conducted clinical trials, there is no role for ordering routine serial blood or imaging tests in monitoring for recurrence in early-stage breast cancer patients. ..
  19. pmc Time trends in radiologists' interpretive performance at screening mammography from the community-based Breast Cancer Surveillance Consortium, 1996-2004
    Laura E Ichikawa
    Group Health Research Institute, Suite 1600, Seattle, WA 98101, USA
    Radiology 256:74-82. 2010
    ..To examine time trends in radiologists' interpretive performance at screening mammography between 1996 and 2004...
  20. ncbi request reprint Effect of breast augmentation on the accuracy of mammography and cancer characteristics
    Diana L Miglioretti
    Center for Health Studies, Group Health Cooperative, Department of Biostatistics, University of Washington, Seattle, Wash 98101, USA
    JAMA 291:442-50. 2004
    ..Breast augmentation is not associated with an increased risk of breast cancer; however, implants may interfere with the detection of breast cancer thereby delaying cancer diagnosis in women with augmentation...
  21. ncbi request reprint The association between depot medroxyprogesterone acetate contraception and bone mineral density in adolescent women
    Delia Scholes
    The Center for Health Studies, Group Health Cooperative, 1730 Minor Avenue, 16th Floor, Seattle, WA, USA
    Contraception 69:99-104. 2004
    ..06). This study did not find a strong association between DMPA use and bone density. Further prospective evaluation of bone density changes with DMPA use and after DMPA discontinuation are needed in this age group...
  22. ncbi request reprint Expanding developmental and behavioral services for newborns in primary care; Effects on parental well-being, practice, and satisfaction
    Brian D Johnston
    Department of Pediatrics, University of Washington, Seattle, WA, USA
    Am J Prev Med 26:356-66. 2004
    ..Both interventions have universal and risk-directed components. Intervention effects in the first 3 months after birth are reported here...
  23. ncbi request reprint Performance of diagnostic mammography for women with signs or symptoms of breast cancer
    William E Barlow
    W E Barlow, Center for Health Studies, Group Health Cooperative, Department of Biostatistics, University of Washington, Seattle 98101 1448, USA
    J Natl Cancer Inst 94:1151-9. 2002
    ..We evaluated whether age, breast density, self-reported breast lump, and previous mammography influence the performance of diagnostic mammography...
  24. ncbi request reprint Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?
    Stephen H Taplin
    Group Health Cooperative, Seattle, WA, USA
    J Natl Cancer Inst 96:1518-27. 2004
    ..However, despite high national mammography screening rates, late-stage breast cancers still occur, possibly because of failures in screening implementation...
  25. pmc Frequent antibiotic use and second breast cancer events
    Heidi S Wirtz
    Departments of Pharmacy, Biostatistics, Epidemiology, and Health Services, University of Washington, Seattle, WA 98101, USA
    Cancer Epidemiol Biomarkers Prev 22:1588-99. 2013
    ..Antibiotic use may be associated with higher breast cancer risk and breast cancer mortality, but no study has evaluated the relation between antibiotic use and second breast cancer events (SBCE)...
  26. pmc Reproductive history and risk of three breast cancer subtypes defined by three biomarkers
    Amanda I Phipps
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, M4 B402, Seattle, WA 98109 1024, USA
    Cancer Causes Control 22:399-405. 2011
    ..31-2.56). Neither parity nor age at first birth was associated with triple-negative breast cancer. In contrast to ER+ and ER-/PR-/HER2+ subtypes, reproductive history does not appear to be a risk factor for triple-negative breast cancer...
  27. ncbi request reprint Factors associated with long-term adherence to annual surveillance mammography among breast cancer survivors
    Heidi S Wirtz
    Department of Pharmacy, University of Washington, 1959 NE Pacific St, Box 357630, Seattle, WA, 98195, USA
    Breast Cancer Res Treat 143:541-50. 2014
    ..Efforts should be undertaken to actively engage breast cancer survivors in managing long-term surveillance care...
  28. pmc Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer
    Jessica Chubak
    Group Health Research Institute, 1730 Minor Ave, Ste 1600, Seattle, WA 98101, USA
    J Natl Cancer Inst 104:931-40. 2012
    ..An alternative is using administrative health-care data to identify second breast cancer events; however, these algorithms must be validated against a gold standard...
  29. ncbi request reprint Longitudinal changes in bone density in relation to oral contraceptive use
    Susan D Reed
    Group Health Cooperative, Seattle, WA, USA
    Contraception 68:177-82. 2003
    ..All p-values for between-group differences were >0.55. In conclusion, within the limitations of this study, OCs did not appear to impact bone density over time in this cohort of reproductive-age women...
  30. pmc Differences among the elderly in the treatment costs of colorectal cancer: how important is race?
    George E Wright
    Department of Family Medicine, University of Washington, Seattle 98195 4982, USA
    Med Care 45:420-30. 2007
    ..Medical expenditures adjusted for price differences are a barometer of total resources devoted to patient care and thus may reflect treatment differentials...
  31. doi request reprint A population-based study of periodontal care among those with and without diabetes
    Katherine M Newton
    Group Health Research Institute, Seattle, WA, USA
    J Periodontol 82:1650-6. 2011
    ..Our objectives were to describe the prevalence of periodontal care (a marker of periodontitis) among persons with and without diabetes and to examine the association between periodontal care and diabetes...
  32. ncbi request reprint Concordance of breast imaging reporting and data system assessments and management recommendations in screening mammography
    Stephen H Taplin
    Center for Health Studies, Group Health Cooperative of Puget Sound, 1730 Minor Ave, Suite 1600, Seattle, WA 98101, USA
    Radiology 222:529-35. 2002
    ..To examine how frequently Breast Imaging Reporting and Data System (BI-RADS) mammographic screening assessments were associated with expected clinical management recommendations...
  33. ncbi request reprint A phase II study of docetaxel and vinorelbine plus filgrastim for HER-2 negative, stage IV breast cancer: SWOG S0102
    Julie R Gralow
    University of Washington School of Medicine Seattle Cancer Care Alliance, 825 Eastlake Avenue East, G3 630, Seattle, WA, 98109, USA
    Breast Cancer Res Treat 143:351-8. 2014
    ..This combination is associated with significant hematologic and nonhematologic toxicity. The safety profile and expense of the filgrastim limit recommendations for routine use. ..
  34. pmc Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population
    Amanda I Phipps
    Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 19:1643-54. 2010
    ..We compared associations between several factors and risk of ductal, lobular, and mixed ductal-lobular breast cancers...
  35. ncbi request reprint Effectiveness of pneumococcal polysaccharide vaccine in older adults
    Lisa A Jackson
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    N Engl J Med 348:1747-55. 2003
    ..In a large population of older adults, we assessed the effectiveness of the pneumococcal vaccine...
  36. ncbi request reprint Oral contraceptives and breast cancer risk overall and by molecular subtype among young women
    Elisabeth F Beaber
    Authors Affiliations Division of Public Health Sciences, Division of Human Biology, Fred Hutchinson Cancer Research Center Departments of Epidemiology, Biostatistics, and Pathology, University of Washington, Seattle, Washington
    Cancer Epidemiol Biomarkers Prev 23:755-64. 2014
    ..Evidence suggests that recent oral contraceptive (OC) use is associated with a small increased breast cancer risk; yet risks associated with contemporary OC preparations and by molecular subtype are not well characterized...
  37. pmc The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)
    William B Wong
    Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA
    Contemp Clin Trials 33:1117-23. 2012
    ..The objective of this study was to assess the value of research of the RxPONDER study, an ongoing comparative effectiveness RCT designed to evaluate a 21-gene profile in early stage, node-positive breast cancer...
  38. pmc Molecular imaging research in the outcomes era: measuring outcomes for individualized cancer therapy
    David A Mankoff
    Seattle Cancer Care Alliance, Radiology, 2nd Floor, 825 Eastlake Avenue East, PO Box 19023, Seattle, WA 98109, USA
    Acad Radiol 14:398-405. 2007
  39. ncbi request reprint Fatal breast cancer risk in relation to use of unopposed estrogen and combined hormone therapy
    Gaia Pocobelli
    Department of Epidemiology, University of Washington, Seattle, WA, USA
    Breast Cancer Res Treat 145:439-47. 2014
    ..To date only a few studies have evaluated fatal breast cancer risk in relation to use of CHT, and collectively the results are inconsistent. ..
  40. ncbi request reprint Training, quality assurance, and assessment of medical record abstraction in a multisite study
    Lisa M Reisch
    Harborview Medical Center, University of Washington School of Medicine, Seattle, WA 98104 2499, USA
    Am J Epidemiol 157:546-51. 2003
    ..Additionally, a masking study with a subsample of subjects may be a feasible and cost-effective alternative to the time- and cost-intensive methodological approach of masking all medical records...
  41. ncbi request reprint Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival
    Lisa K Dunnwald
    Division of Nuclear Medicine, Department of Radiology, University of Washington, Seattle, Washington 98195, USA
    Cancer 103:680-8. 2005
    ..The pathologic response of LABC to presurgical treatment regimens is a prognostic indicator of survival. The authors tested whether MIBI uptake posttherapy predicted survival...
  42. pmc p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy
    Peggy L Porter
    Division of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N, Seattle, WA 98109, USA
    J Natl Cancer Inst 98:1723-31. 2006
    ..We studied these markers in a clinical trial setting with patients with breast cancer treated by a uniform drug regimen so that treatment was not associated with variability in outcome...
  43. pmc Contrasting two frameworks for ROC analysis of ordinal ratings
    Daryl E Morris
    Biostatistics and Biomathematics, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, USA
    Med Decis Making 30:484-98. 2010
    ..The ordinal regression method is the standard approach used when evaluating tests with ordinal values. The direct ROC modeling method is a more recently developed approach, motivated by applications to tests with continuous values...
  44. ncbi request reprint Comparison of survival outcomes among cancer patients treated in and out of clinical trials
    Joseph M Unger
    Affiliations of authors SWOG Statistical Center, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA JMU, WEB, ML University of Washington, Department of Health Services Research, Seattle, WA DPM Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA SDR, RE Division of Hematology Oncology, Columbia University, New York, NY DLH
    J Natl Cancer Inst 106:dju002. 2014
    ..Clinical trials test the efficacy of a treatment in a select patient population. We examined whether cancer clinical trial patients were similar to nontrial, "real-world" patients with respect to presenting characteristics and survival...
  45. pmc Results from a randomized trial of a web-based, tailored decision aid for women at high risk for breast cancer
    Matthew P Banegas
    University of Washington, Department of Health Services, Seattle, WA, USA
    Patient Educ Couns 91:364-71. 2013
    ..To assess the impact of Guide to Decide (GtD), a web-based, personally-tailored decision aid designed to inform women's decisions about prophylactic tamoxifen and raloxifene use...
  46. ncbi request reprint Injectable hormone contraception and bone density: results from a prospective study
    Delia Scholes
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Epidemiology 13:581-7. 2002
    ..Depot medroxyprogesterone acetate (DMPA) injectable contraception may decrease bone density and increase the risk for osteoporosis in later life. Prospective data are scarce, especially of the effects of DMPA discontinuation on bone...
  47. ncbi request reprint Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial
    Linda Teri
    Department of Psychosocial and Community Health, University of Washington, Seattle 98195, USA
    JAMA 290:2015-22. 2003
    ..Exercise training for patients with Alzheimer disease combined with teaching caregivers how to manage behavioral problems may help decrease the frailty and behavioral impairment that are often prevalent in patients with Alzheimer disease...
  48. ncbi request reprint Expanding developmental and behavioral services for newborns in primary care: program design, delivery, and evaluation framework
    Colleen E Huebner
    Maternal and Child Health Program, Department of Health Services, University of Washington, Seattle, Washington, USA
    Am J Prev Med 26:344-55. 2004
    ....
  49. pmc A randomized trial comparing acupuncture, simulated acupuncture, and usual care for chronic low back pain
    Daniel C Cherkin
    Center for Health Studies, 1730 Minor Avenue, Seattle, WA 98101, USA
    Arch Intern Med 169:858-66. 2009
    ..This trial addresses the importance of needle placement and skin penetration in eliciting acupuncture effects for patients with chronic low back pain...
  50. pmc Cross-sectional study of periodontal care and Glycosylated Hemoglobin in an insured population
    Leslie Spangler
    Group Health Research Institute, Seattle, Washington, USA
    Diabetes Care 33:1753-8. 2010
    ..Compare GHb among people with diabetes who have and have not received periodontal care...
  51. doi request reprint High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials
    Donald A Berry
    Division of Quantitative Sciences, Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77230 1402, USA
    J Clin Oncol 29:3214-23. 2011
    ..Individual trials have had limited power to show overall benefit or benefits within subsets...